CONFIDENTIAL
ARVIND KUMAR C. AGGARWAL., M.D.
Board certified in Hematology and Medical Oncology
5038 Tarry Glen drive
Suwanee
Georgia 30024
3/13//2008R
TEL.: (678) 294 2675
FAX: (478) 275-1191
Email: mdaggarwal@dublinoncology.com
Citizenship:
Marital Status:
USA
Married, 2 Children
Training Experience and Positions Held:
3/2008-Present
Dublin Hematology Oncology Care, PC
Private Practice/Staff Physician
2/2005 – 2/2008
Atlanta VA Medical Center, Atlanta, GA
Staff Physician, Hematology/Oncology
Emory University School of Medicine Faculty Member
Emory University Winship Cancer Institute Clinical Instructor and
ECOG Clinical Investigator
1/2005 -2/2005
Visiting Family pending completion of paperwork/transfer to VA
Atlanta from Kansas City
7/1996 – 12/2004
Kansas City VA Medical Center, Kansas City, MO
Staff Physician, Internal Medicine, Hematology/Oncology
University of Kansas School of Medicine Faculty member
SWOG Clinical Investigator
7/1993 – 6/1996
University of Kansas Medical Center, Kansas City, Kansas
Fellow in Hematology/Clinical Oncology
7/1990 – 6/1993
Grant Hospital of Chicago, Chicago, Illinois
Resident in Internal Medicine
5/1989 – 6/1990
Aga Khan Hospital, Department of Medicine, Nairobi, Kenya
Senior House Officer: Care of patients and supervision of Medical
Students
5/1987 – 5/1989
Aga Khan Hospital, Department of Ambulatory Care
Medical Officer. Care and referral of patients in the Emergency
room and Outpatient general medicine clinics,
8/1986 – 4/1987
7/1985 – 8/1986
Education:
8/1984 – 9/1984
10/1979 – 11/1985
New Nyanza General Hospital, Kisumu, Kenya
Medical Officer in General Surgery. Responsible for Management
of patients and supervision of Interns.
Kenyatta National Hospital, Nairobi, Kenya
Rotating Internship (3 months each in General Surgery, Internal
Medicine, Obstetrics and Gynecology, Pediatrics)
East Birmingham Hospital. Birmingham, England
Elective student in Internal Medicine and General Surgery
University of Nairobi Medical School, Nairobi, Kenya
Graduated with a M.B.Ch.B. Degree in November 1985.
Certifications and Examinations:
Controlled Substance Registration Certificate, Drug Enforcement Administration,
Washington, US Dept of Justice, Expires 06/2010
1993, recertified 11/2003 Exp 2013
American Board of Internal Medicine
11/1996, recertified 11/2003 Exp 2016 Diplomate in Subspecialty of Hematology
11/1997, recertified 11/2003 Exp 2017 Diplomate in Subspecialty of Medical Oncology
12/1991
FLEX Illinois
10/1987
ECFMG (valid indefinitely)
Licensure:
State of Georgia # 056400(current), Illinois # 036-085013(inactive),
Kansas # 24642(inactive)
Awards:
Outstanding Resident 1993, Department of Medicine, Grant Hospital of Chicago,
Chicago., IL
Memberships:
American Society of Hematology
American Society of Clinical Oncology
Eastern Co-operative Oncology Group
Hospital Committees:
-Member of the Cancer Committee, (Atlanta VAMC)
-Member Oncology Review and Referral Board for Central Alabama Veterans Health
Care System(CAVHCS)
-Member of the Executive Committee of the Medical Staff (Kansas City VAMC)
-Member of Palliative Care Committee (Kansas City VAMC)
-Member of Transfusion and Tissue Committee (Topeka VAMC)
Other Professional Activities:
5/ 30 – 6/12/1993
Molecular Biology and Biotechnology Workshop, Selected
Participant, Sponsored by Smith College, Northhampton,
MA
March 3-15/1996
Blood Banking Lecture Series, Kansas City, MO
Research Experience and Activities:
-Phase 1 study of 5FU/Taxol in breast, ovarian, head and neck, esophageal cancers.
-Microsatellite alterations in head and neck cancer.
-Pharmacokinetics of Taxol in combination with infusional 5FU.
-Amgen 20020132: A study to assess symptom burden in subjects with nonmyeloid
malignancies receiving chemotherapy and Aranesp.
-Phase 3 study to evaluate efficacy and safety of front-line therapy with Campath vs
Chlorambucil in patients with progressive B-cell Chronic Lymphocytic Leukemia.
-Kenya, The University of Nairobi, Nairobi, Kenya
Nutritional Surveys in Machakos and Kajiado Districts in Kenya in 1984
-Grant Hospital of Chicago ,Illinois
Factors influencing in vitro isolation of campylobacter sp in stool specimens.
.
Publications:
Full Length Articles:
Aggarwal A, Doolittle GC: Autoimmune thrombocytopenic purpura associated with
hyperthyroidism in a single individual. Southern Medical J, 90:933-936. 1997.
Van Veldhuizen. PJ. Reed G. Aggarwal A. Baranda J. Zulfiqar M. Williamson S.
Docetaxel and ketoconazole in advanced hormone-refractory prostate carcinoma: a phase
I and pharmacokinetic study. Cancer. 98(9):1855-62, 2003.
Abstracts:
Aggarwal A, Doolittle G: Autoimmune thrombocytopenic purpura associated with
hyperthyroidism: A case report and review of the literature. Proc ACP Kansas Chapter
Scientific Meeting, p. 80, September 1995.
Williamson SK, Iqbal M, Vogel S, Pluenneke R, Chapman J, Weed J, Van Veldhuizen P,
Campbell L, Aggarwal A, Grahm D, Vinyard R, Johnson N: Phase I/II trial of weekly
gemcitabine and low dose continuous infusions 5-FU in patients with advanced
malignancies. Proc. ASCO 18. # 895, 1999.
Ribeiro M, Aggarwal A, Harris W, Ingram J, Pradhan A, Robinson C
A model of multidisciplinary cancer care through telemedicine coordination of care and
therapy administration at a certified Teaching comprehensive Cancer Program VISN 7Atlanta VAMC/CAVHCS
Presented at Association of VA Hematology/Oncology meeting, Oct 13-15,2006,
Cincinnati, Ohio
Presentations:
-Head and Neck Cancers core lecture to Students, Residents and Fellows, Primary Care
Providers
-Oncologic Emergencies core lecture to Students, Residents and Fellows, Primary care
Providers
-Deep Venous Thrombosis
-Approach to the Bleeding Patient
-Anticoagulant Therapy
-Kansas Chapter of the American College of Physicians Meeting, Wichita, KS
“Autoimmune Thrombocytopenic Purpura Associated with Hyperthyroidism, A Case
Report/Review of the Literature,” September 9, 1995.
-KUMC Oncology Noon Conference, “Oncologic Emergencies,” August 29, 1995.
-KUMC Oncology Noon Conference, “Porphyrias” May, 1996.
-Oncology Noon Conference, KUMC, “Testicular Cancer,” December 8, 1994.
-Use of GCSF in febrile Neutropenic patients 5/1993